194 related articles for article (PubMed ID: 15131765)
1. Fenofibrate prevents obesity and hypertriglyceridemia in low-density lipoprotein receptor-null mice.
Jeong S; Kim M; Han M; Lee H; Ahn J; Kim M; Song YH; Shin C; Nam KH; Kim TW; Oh GT; Yoon M
Metabolism; 2004 May; 53(5):607-13. PubMed ID: 15131765
[TBL] [Abstract][Full Text] [Related]
2. Fenofibrate improves lipid metabolism and obesity in ovariectomized LDL receptor-null mice.
Yoon M; Jeong S; Lee H; Han M; Kang JH; Kim EY; Kim M; Oh GT
Biochem Biophys Res Commun; 2003 Feb; 302(1):29-34. PubMed ID: 12593843
[TBL] [Abstract][Full Text] [Related]
3. Effects of fenofibrate on high-fat diet-induced body weight gain and adiposity in female C57BL/6J mice.
Jeong S; Han M; Lee H; Kim M; Kim J; Nicol CJ; Kim BH; Choi JH; Nam KH; Oh GT; Yoon M
Metabolism; 2004 Oct; 53(10):1284-9. PubMed ID: 15375783
[TBL] [Abstract][Full Text] [Related]
4. Fenofibrate regulates obesity and lipid metabolism with sexual dimorphism.
Yoon M; Jeong S; Nicol CJ; Lee H; Han M; Kim JJ; Seo YJ; Ryu C; Oh GT
Exp Mol Med; 2002 Dec; 34(6):481-8. PubMed ID: 12526091
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor-alpha selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice.
Srivastava RA; Jahagirdar R; Azhar S; Sharma S; Bisgaier CL
Mol Cell Biochem; 2006 Apr; 285(1-2):35-50. PubMed ID: 16477380
[TBL] [Abstract][Full Text] [Related]
6. Trans-10,cis-12 CLA increases liver and decreases adipose tissue lipids in mice: possible roles of specific lipid metabolism genes.
Warren JM; Simon VA; Bartolini G; Erickson KL; Mackey BE; Kelley DS
Lipids; 2003 May; 38(5):497-504. PubMed ID: 12880104
[TBL] [Abstract][Full Text] [Related]
7. Activation of peroxisome proliferator-activated receptor-alpha in mice induces expression of the hepatic low-density lipoprotein receptor.
Huang Z; Zhou X; Nicholson AC; Gotto AM; Hajjar DP; Han J
Br J Pharmacol; 2008 Oct; 155(4):596-605. PubMed ID: 18852694
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor alpha is not rate-limiting for the lipoprotein-lowering action of fish oil.
Dallongeville J; Baugé E; Tailleux A; Peters JM; Gonzalez FJ; Fruchart JC; Staels B
J Biol Chem; 2001 Feb; 276(7):4634-9. PubMed ID: 11050100
[TBL] [Abstract][Full Text] [Related]
9. Fenofibrate and rosiglitazone lower serum triglycerides with opposing effects on body weight.
Chaput E; Saladin R; Silvestre M; Edgar AD
Biochem Biophys Res Commun; 2000 May; 271(2):445-50. PubMed ID: 10799317
[TBL] [Abstract][Full Text] [Related]
10. A Novel Selective PPARα Modulator (SPPARMα), K-877 (Pemafibrate), Attenuates Postprandial Hypertriglyceridemia in Mice.
Sairyo M; Kobayashi T; Masuda D; Kanno K; Zhu Y; Okada T; Koseki M; Ohama T; Nishida M; Sakata Y; Yamashita S
J Atheroscler Thromb; 2018 Feb; 25(2):142-152. PubMed ID: 28781340
[TBL] [Abstract][Full Text] [Related]
11. Dietary isoflavone supplementation modulates lipid metabolism via PPARalpha-dependent and -independent mechanisms.
Mezei O; Li Y; Mullen E; Ross-Viola JS; Shay NF
Physiol Genomics; 2006 Jun; 26(1):8-14. PubMed ID: 16507786
[TBL] [Abstract][Full Text] [Related]
12. Kaempferol regulates the lipid-profile in high-fat diet-fed rats through an increase in hepatic PPARα levels.
Chang CJ; Tzeng TF; Liou SS; Chang YS; Liu IM
Planta Med; 2011 Nov; 77(17):1876-82. PubMed ID: 21728151
[TBL] [Abstract][Full Text] [Related]
13. Triglyceridemia and peroxisome proliferator-activated receptor-alpha expression are not connected in fenofibrate-treated pregnant rats.
Soria A; González Mdel C; Vidal H; Herrera E; Bocos C
Mol Cell Biochem; 2005 May; 273(1-2):97-107. PubMed ID: 16013444
[TBL] [Abstract][Full Text] [Related]
14. Fenofibrate modulates cardiac and hepatic metabolism and increases ischemic tolerance in diet-induced obese mice.
Aasum E; Khalid AM; Gudbrandsen OA; How OJ; Berge RK; Larsen TS
J Mol Cell Cardiol; 2008 Jan; 44(1):201-9. PubMed ID: 17931655
[TBL] [Abstract][Full Text] [Related]
15. Fenofibrate Regulates Visceral Obesity and Nonalcoholic Steatohepatitis in Obese Female Ovariectomized C57BL/6J Mice.
Shin Y; Lee M; Lee D; Jang J; Shin SS; Yoon M
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916086
[TBL] [Abstract][Full Text] [Related]
16. Changes in liver PPARalpha mRNA expression in response to two levels of high-safflower-oil diets correlate with changes in adiposity and serum leptin in rats and mice.
Hsu SC; Huang CJ
J Nutr Biochem; 2007 Feb; 18(2):86-96. PubMed ID: 16713235
[TBL] [Abstract][Full Text] [Related]
17. Fenofibrate prevents and reduces body weight gain and adiposity in diet-induced obese rats.
Mancini FP; Lanni A; Sabatino L; Moreno M; Giannino A; Contaldo F; Colantuoni V; Goglia F
FEBS Lett; 2001 Feb; 491(1-2):154-8. PubMed ID: 11226439
[TBL] [Abstract][Full Text] [Related]
18. Enzymatically synthesized glycogen reduces lipid accumulation in diet-induced obese rats.
Furuyashiki T; Ogawa R; Nakayama Y; Honda K; Kamisoyama H; Takata H; Yasuda M; Kuriki T; Ashida H
Nutr Res; 2013 Sep; 33(9):743-52. PubMed ID: 24034574
[TBL] [Abstract][Full Text] [Related]
19. Dietary isohumulones, the bitter components of beer, raise plasma HDL-cholesterol levels and reduce liver cholesterol and triacylglycerol contents similar to PPARalpha activations in C57BL/6 mice.
Miura Y; Hosono M; Oyamada C; Odai H; Oikawa S; Kondo K
Br J Nutr; 2005 Apr; 93(4):559-67. PubMed ID: 15946420
[TBL] [Abstract][Full Text] [Related]
20. The PPARα agonist fenofibrate suppresses B-cell lymphoma in mice by modulating lipid metabolism.
Huang J; Das SK; Jha P; Al Zoughbi W; Schauer S; Claudel T; Sexl V; Vesely P; Birner-Gruenberger R; Kratky D; Trauner M; Hoefler G
Biochim Biophys Acta; 2013 Oct; 1831(10):1555-65. PubMed ID: 23628473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
